Results-A total of 273 subjects (69%) collected a PEF meter but a completed record sheet was returned by only 247 (62%); this was still significantly more than the 202 subjects (54%) who attended for and successfully completed a challenge test. Amplitude % mean was higher in women than in men (9.7% v 8.5%). In multiple regression analysis amplitude % mean increased significantly with age, mean skin weal diameter, and with current smoking. The odds of having a PD20 below 24 5,umol increased with mean skin weal diameter and were greater in current smokers. Neither age nor sex had a significant effect on bronchial reacitvity but there were significant interactions between age and the effects of both smoking and atopy. Conclusions-The higher response rate associated with the use of PEF variability measurement, and the association with factors implicated in the pathogenesis of airways disease, suggest that PEF variability would be a useful measurement to employ in epidemiological studies. (Thorax 1993;48:899-905) 
ated with airways disease, and to compare their response rates. Methods-Subjects aged 18-65 were randomly selected from the electoral register of an administrative area in eastern England and randomised to attend either for a bronchial challenge test measuring the provocative dose of methacholine producing a 20% fall in FEV, (PD20), or to measure PEF at two hourly intervals during waking hours for one week. Skin tests with common allergens were performed and a smoking history obtained. PEF variability was expressed as the amplitude % mean (highest -lowest x 100/mean). Results-A total of 273 subjects (69%) collected a PEF meter but a completed record sheet was returned by only 247 (62%); this was still significantly more than the 202 subjects (54%) who attended for and successfully completed a challenge test. Amplitude % mean was higher in women than in men (9.7% v 8.5%). In multiple regression analysis amplitude % mean increased significantly with age, mean skin weal diameter, and with current smoking. The odds of having a PD20 below 24 5,umol increased with mean skin weal diameter and were greater in current smokers. Neither age nor sex had a significant effect on bronchial reacitvity but there were significant interactions between age and the effects of both smoking and atopy. Conclusions-The higher response rate associated with the use of PEF variability measurement, and the association with factors implicated in the pathogenesis of airways disease, suggest that PEF variability would be a useful measurement to employ in epidemiological studies.
(Thorax 1993;48:899-905)
The inclusion of an objective measurement of bronchial reactivity in epidemiological investigations of asthma overcomes some of the problems of identifying asthma in the community and enables comparisons to be made between studies performed in different countries. It has become clear, however, that bronchial reactivity does not have as precise a relationship to the clinical diagnosis of asthma as was originally thought.' There are, in addition, several practical problems associated with the measurement of bronchial reactivity in the community, including the invasive nature of challenge tests, the necessity of having a doctor present during the test, and the difficulties of obtaining a conventional measurement of reactivity such as the provocative dose of methacholine producing a 20% fall in FEV, (PD20) in most subjects in a random population sample when dosage of bronchoconstrictor agents is limited by side effects.
We have explored the use of serial peak expiratory flow (PEF) recordings to try to circumvent some of these problems. In addition to the practical benefits, this method has the advantage of measuring directly the diurnal variability of airway calibre which is a cardinal feature of asthma. We have shown that collection of PEF recordings from previously untrained subjects is feasible, and that the data can be analysed to provide a numerical index of PEF variability which shows the expected relationship to the diagnosis of asthma.6 Although these findings suggest that the use of PEF variability might be an alternative to measurement of bronchial reactivity for community surveys of asthma prevalence, there are several unanswered questions. Our earlier study was performed in a small random sample together with a group of subjects selected because of respiratory symptoms, and did not permit an adequate consideration of the association of PEF variability with such factors as atopy and smoking. These associations are important since the value of PEF variability as an epidemiological tool would be questionable if it showed no relationship to factors implicated in the development and clinical diagnosis of airways disease. Furthermore, the possibility that measurement of PEF variability would be more acceptable to subjects in a community setting, and thereby achieve higher response rates, has not been explored.
We have therefore measured PEF peak flow meter and how to fill in a purpose designed record sheet with spaces for recordings at two hourly intervals throughout the day, commencing at 02-00 hours. They were asked to record their PEF within 15 minutes of the times shown every day for a week during waking hours. It was emphasised that spaces should be left blank rather than insert inaccurate data if a measurement was missed. Subjects were asked to return the meter and completed record sheet by post and were given a strong stamped addressed envelope for this purpose. If the meter was not returned by post subjects were visited at home.
SK1N TESTS
Skin prick tests were performed on the ventral aspect of the forearm using Dermatophagoides pteronnysinus, grass pollen, and cat dander as test reagents with histamine and saline as controls. Skin weal size was measured after 10 minutes as the mean of the largest diameter and that at right angles to-it, excluding any pseudopodial outgrowths.
ANALYSIS OF RESULTS
The results of the challenge tests were analysed by a curve fitting method8 to determine the methacholine PD20. Extrapolation of the curve to one doubling dose above the maximum dose administered-that is, to umol-was carried out if the FEV, had not Smoking history was determined from two questions, one asking if subjects had ever smoked on a daily basis for at least a year, and the second if they had smoked at all in the last month. Subjects answering both questions affirmatively were classified as current smokers, those answering both negatively as non-smokers, and those who had had no cigarettes in the last month but had smoked for a year or more in the past were classified as ex-smokers.
The mean skin weal diameter of each subject was calculated by subtracting the saline control value from each of the house dust, grass, and cat weal diameters, and taking the mean of these three values.
The relationship between amplitude % mean and age, sex, mean skin weal diameter, and smoking history was determined by multiple linear regression with amplitude % mean as the dependent variable. Sex and smoking were entered as categorical factors using three levels of smoking representing current, exsmokers, and non-smokers. Identical analyses were performed with the two components of amplitude % mean, amplitude and mean PEF as dependent variables. A similar analysis was performed for the results of bronchial challenge tests but in this case multiple logistic regression was used with reactor status as the categorical dependent variable, a reactor being defined as a subject with a PD20 value below 24-5 5umol. The interactions between age and both atopy and smoking were tested for significance. Age group (years) Figure 3 Percentage of reactors (PD20 <24 5 mol), with 95% confidence limits, by age and smoking history. Current smokers (X) and non-smokers (X) are shown; there were few ex-smokers in the younger age groups and they are omitted.
decline in the effects of atopy with increasing age (table 4, fig 2) , and between smoking and age, the increased reactivity in current smokers being less pronounced with age (table 4, fig 3) .
Discussion
The associations of bronchial reactivity with smoking and atopy have been reported previously, but this is the first time that the relations of these factors to PEF variability have been studied in randomly selected subjects. Although bronchial reactivity and PEF variability are both measures of airway lability, they are obtained in different ways and are likely to reflect different aspects of airway behaviour. The results from this study in randomly selected subjects, however, show that both measurements vary with factors known to be associated with airways disease. The strength of the associations of the two measurements with these factors cannot be compared since the measurements were not made in identical subject groups. Amplitude % mean was positively associated with mean skin weal diameter, the increase with increasing weal diameter being produced by complementary changes in absolute amplitude (increase) and mean PEF (decrease). The difference is present in all age groups except those aged > 54 years (fig 2) . Atopic status is one of the major risk factors for the development of asthma and any proposed measure of airway lability would be expected to show a relationship to atopy. Such an association might also be expected on the basis of the changes which occur when allergen challenge is carried out under controlled laboratory conditions9-"1: airway calibre falls as an immediate response to allergen challenge followed several hours later by an increase in bronchial reactivity. Natural exposure of atopic asthmatic subjects to allergen would thus be expected to lower PEF readings directly and to increase the susceptibility to bronchoconstrict when exposed to other stimuli, leading to increased PEF variability.
The odds of having a methacholine PD20 below 24-5 ,imol also increased as skin weal diameter increased. Several previous surveys have shown a relationship between atopic status and bronchial hyperreactivity.12-'7 Seasonal variation in bronchial reactivity has been found in wheat workers18 and in a community population selected because of occasional wheeze,'9 and these changes are assumed to be related to seasonal changes in allergen levels. In the laboratory allergen challenge can produce an increase in bronchial reactivity9-1 and the airway response to allergen can be predicted from a prior knowledge of the histamine PD20. [20] [21] [22] [23] We also found, as in a previous study,'3 an interaction between age and atopy with a significant reduction in the proportion of atopic subjects with measurable PD20 values with increasing age.
Current smokers had higher levels of amplitude % mean than non-smokers or exsmokers. The difference between smoking categories was slightly more pronounced in the younger age groups but this trend was not statistically significant. The increased values in young current smokers suggest that the effect of cigarettes on the airways can occur after relatively short exposure. As with atopy the changes in amplitude % mean with smoking history were contributed to by an increase in the absolute amplitude and a decrease in mean PEF.
Most studies which have considered the effects of cigarette smoking on bronchial reactivity in community samples have shown, as in the present study, an increased proportion of smokers among subjects with a measurable PD20 value."32428 In some such studies the effects of smoking have been seen mainly in subjects with low baseline airway calibre,2728 a finding consistent with the theory that long term smoking alters bronchial reactivity through an effect on airway calibre. There is also evidence of short term effects of smoking on airway calibre and bronchial reactivity,2930 and in our study the increased proportion of current smokers with a measurable PD20 was present, as with amplitude % mean, in all age groups and was, in fact, more obvious in the younger age groups as shown in fig 3. The figure may exaggerate the extent of the increase in the youngest age group which contained only seven smokers, but the results suggest that smoking can alter bronchial reactivity after relatively short exposure when changes in airway calibre would be expected to be minimal. The effect of smoking on bronchial reactivity remained after controlling for baseline FEV1, again favouring the suggestion that smoking may have a more direct influence on reactivity.
Previous reports which have considered the effects of age on bronchial reactivity have generally, like the present study, been based on cross sectional surveys. Studies which have included both children and adults have shown a fall in the proportion of reactors to methacholine and cold air with increasing age,"32 the lowest levels being seen in subjects in their forties. In adults there appears to be an increase in the number of reactors as age increases above 40-50 years,33-36 although one recent study has shown the opposite.37 In combination these results tend to suggest a U-shaped distribution with reactivity greatest in early and late adult life. In contrast to PD20, amplitude % mean showed a small steady increase with age ( fig 2) . This appears to be due principally to the well recognised decline in mean PEF with age, since absolute amplitude was relatively constant across the age range studied. Although the age related variation in amplitude % mean was significant it was not large, the expected value for amplitude % mean in a non-smoking nonatopic man changing from 6&6% at age 20 to 8-5% at age 60. There was no difference in PD20 values between men and women, and no consistent association with sex has been reported in adults.5'37 Both mean PEF and absolute amplitude were lower in women than in men, but the difference was proportionately larger for mean PEF so that amplitude % mean was significantly greater in women. In our sample more women than men had a history of asthma (9-7% v 6&1%) which may account for some of the difference in PEF variability between the sexes, but amplitude % mean was also higher in women in the subjects who reported no asthma. In practice the sex difference could be allowed for in studies using amplitude % mean measurements as is currently done for other indices of lung function such as FEVI.
One of the main reasons for performing this study was to compare response rates for the two survey methods. In terms of the number of people attending for a challenge test or to collect a PEF meter there was a distinctly better response with PEF recordings. Some subjects failed to return their PEF record, however, and some were unable to complete challenge tests, so that the final difference was 8-7%. Of the 26 subjects who accepted a PEF meter but failed to return a completed record 23 by experienced personnel. Appointment systems for PEF recordings are easier to organise and several subjects can be instructed together. If subjects need to be visited at home it is much easier to deliver a PEF meter and give instructions than to perform a challenge test, and the PEF method can be used by non-medically trained personnel. There are limitations to PEF measurements. Some researchers may not feel comfortable with the lack of supervision the method entails. The need to correct for age and sex adds a minor complication. Perhaps most important is the finding from a previous study, in subjects selected because of a history of wheeze, that subjects who had been given a diagnosis of asthma were separated more clearly from non-asthmatic subjects by use of bronchial reactivity than by PEF variability measurements.'8 However, there was little difference between the measurements when the relationships to respiratory symptoms were compared.
In summary, we have confirmed in a random population sample that bronchial reactivity measurements are associated with atopy and smoking, and have shown that these factors are also related to increased PEF variability. The effects of atopy and smoking on bronchial reactivity show interactions with age which we did not find for PEF variability but, despite this difference, our findings suggest that measurement of PEF variability is a suitable alternative to bronchial challenge tests for epidemiological studies. In particular, it may be more suitable for studies involving repeated measurements in which its greater acceptability and absence of censored data would be important. A measure of PEF variability can be obtained in all subjects in a population sample who accept a peak flow meter; it appears to produce a higher response rate than bronchial challenge tests and is associated with factors known to be related to airways disease. 
